New
Impli
The AI engine Fit Assessment
BetaThe company will be attending the 2024 Health Tech Forward Event
Blurb
Impli creates a real-time hormone monitoring device for IVF to enhance fertility treatment.
HQ Location
United Kingdom
Founded
2019
Employees
1 - 10
Total funding raised
Not available
Last Funding Event
Not available
Smart insights
- Catherine Msc (Chief People Officer) worked at Lilium as Head of People Business Partnering for 1.5 years (2021 - 2022)
- Val Miftakhov (Founder & CEO) worked at Google in various roles, including Head of R&D, Google for Work Incubation, for a total of 4 years (2012 - 2016)
- 6m headcount growth: 25%
- 1Y headcount growth: 94%
- Headcount-to-last-round ratio: 5.3 employees/$M
Developer of a monitoring device designed to continuously track hormone levels in patients undergoing fertility treatments. The company's device monitors hormone levels directly from subcutaneous tissue to make informed treatment decisions, enabling healthcare providers to implement preventive measures before complications arise.